# A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis

> **NCT01097590** · PHASE1 · COMPLETED · sponsor: **IBD Column Therapies International AB** · enrollment: 23 (actual)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DEVICE:** Active TLA Gut™ column
- **DEVICE:** Placebo

## Key facts

- **NCT ID:** NCT01097590
- **Lead sponsor:** IBD Column Therapies International AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-10
- **Final completion:** 2011-11
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01097590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01097590, "A Study to Evaluate a Leukapheresis Treatment in Patients With Ulcerative Colitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01097590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*